−0.013EUR
−1.26 MEUR
104.72 KEUR
34.50 M
About BIOMARK DIAGNOSTICS INC.
Sector
Industry
CEO
Rashid Ahmed Maula Bux
Website
Headquarters
Richmond
Founded
2014
FIGI
BBG007LXD8B4
BioMark Diagnostics, Inc. engages in the development and commercialization of cancer diagnostic solutions to detect, monitor, and assess treatment for cancer. The company was founded by Rashid Ahmed Bux on June 19, 2014 and is headquartered in Richmond, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BIOMARK DIAGNOSTICS INC. stocks are traded under the ticker 20B.
Yes, you can track BIOMARK DIAGNOSTICS INC. financials in yearly and quarterly reports right on TradingView.
20B net income for the last quarter is −278.06 K EUR, while the quarter before that showed −146.55 K EUR of net income which accounts for −89.73% change. Track more BIOMARK DIAGNOSTICS INC. financial stats to get the full picture.
No, 20B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 20B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOMARK DIAGNOSTICS INC. stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOMARK DIAGNOSTICS INC. EBITDA is −995.55 K EUR, and current EBITDA margin is −1.01 K%. See more stats in BIOMARK DIAGNOSTICS INC. financial statements.